Nanoparticulate vaccine inhibits tumor growth via improved T cell recruitment into melanoma and huHER2 breast cancer.
Zupančič E, Curato C, Kim JS, Yeini E, Porat Z, Viana AS, Globerson-Levin A, Waks T, Eshhar Z, Moreira JN, Satchi-Fainaro R, Eisenbach L, Jung S, Florindo HF.
Zupančič E, et al. Among authors: moreira jn.
Nanomedicine. 2018 Apr;14(3):835-847. doi: 10.1016/j.nano.2017.12.011. Epub 2018 Jan 3.
Nanomedicine. 2018.
PMID: 29306001